Nathalang Oytip, Intharanut Kamphon, Leetrakool Nipapan, Mitundee Supattra, Kupatawintu Pawinee
Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumtani, Thailand.
Blood Bank Section, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Blood Res. 2020 Jun 30;55(2):107-111. doi: 10.5045/br.2020.2020042.
SERF(+) is a high prevalence antigen in the Cromer blood group system that is encoded by a allele. The SERF(-) on red cells is caused by a single nucleotide variation, c.647C>T, in exon 5 of the gene. Alloanti-SERF was found in a pregnant Thai woman, and a SERF(-) individual was found among Thai blood donors. Since anti-SERF is commercially unavailable, this study aimed to develop appropriate genotyping methods for and alleles and predict the SERF(-) phenotype in Thai blood donors.
DNA samples obtained from 1,580 central, 300 northern, and 427 southern Thai blood donors were genotyped for and allele detection using in-house PCR with sequence-specific primer (PCR-SSP) confirmed by DNA sequencing.
Validity of the PCR-SSP genotyping results agreed with DNA sequencing; / was the most common (98.42%, 98.00%, and 98.59%), followed by / (1.58%, 2.00%, and 1.41%) among central, northern, and southern Thais, respectively. / was not detected in all three populations. The alleles found in central Thais did not significantly differ from those found in northern and southern Thais.
This study is the first to distinguish the predicted SERF phenotypes from genotyping results obtained using in-house PCR-SSP, confirming that the allele frequency ranged from 0.007 to 0.010 in three Thai populations. This helps identify the SERF(-) phenotype among donors and patients, ultimately preventing adverse transfusion reactions.
SERF(+)是克罗马血型系统中一种高流行率抗原,由一个等位基因编码。红细胞上的SERF(-)是由该基因第5外显子中的单核苷酸变异c.647C>T引起的。在一名泰国孕妇中发现了抗-SERF,并且在泰国献血者中发现了一名SERF(-)个体。由于抗-SERF没有商业供应,本研究旨在开发适用于该等位基因和等位基因的基因分型方法,并预测泰国献血者的SERF(-)表型。
从1580名泰国中部、300名泰国北部和427名泰国南部献血者获取的DNA样本,使用内部序列特异性引物聚合酶链反应(PCR-SSP)进行等位基因和等位基因检测基因分型,并通过DNA测序进行确认。
PCR-SSP基因分型结果的有效性与DNA测序结果一致;/在泰国中部、北部和南部人群中分别是最常见的(98.42%、98.00%和98.59%),其次是/(1.58%、2.00%和1.41%)。在所有三个群体中均未检测到/。泰国中部人群中发现的等位基因与泰国北部和南部人群中发现的等位基因没有显著差异。
本研究首次从使用内部PCR-SSP获得的基因分型结果中区分出预测的SERF表型,证实了该等位基因频率在三个泰国人群中为0.007至0.010。这有助于在献血者和患者中识别SERF(-)表型,最终预防不良输血反应。